Riesgo cardiovascular en la artritis reumatoide. ¿Hasta dónde?

scientific article published on 01 September 2006

Riesgo cardiovascular en la artritis reumatoide. ¿Hasta dónde? is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P356DOI10.1016/S1699-258X(06)73051-0
P698PubMed publication ID21794333

P50authorLoreto CarmonaQ56419499
P2093author name stringVíctor Martínez Taboada
P2860cites workReduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patientsQ38482066
Rheumatoid arthritis and mortality. A longitudinal study in Pima Indians.Q43616578
Joint swelling as a predictor of death from cardiovascular disease in a population study of Pima IndiansQ44170460
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyQ44973310
Effect of glucocorticoids on the arteries in rheumatoid arthritisQ45184227
Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients.Q50701881
Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohortQ57804967
Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjectsQ73628316
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factorsQ77406810
Cardiovascular death in rheumatoid arthritis: a population-based studyQ81484761
Methotrexate treatment and mortality in rheumatoid arthritisQ94154076
Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritisQ95717263
Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control studyQ24812262
Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general populationQ24816136
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trialQ34327988
Coronary artery disease and rheumatoid arthritisQ34531168
No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onsetQ35549071
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990sQ35554980
Lower limb arterial incompressibility and obstruction in rheumatoid arthritisQ35555347
Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope allelesQ35636886
Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidityQ35799612
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.Q36031031
P433issue5
P304page(s)221-223
P577publication date2006-09-01
P1433published inReumatología ClínicaQ26842348
P478volume2

Search more.